Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash flows from operating activities:
Net loss	$ (1,573,303)	$ (501,851)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	6,412	6,973
Amortization of debt discounts and deferred financing costs	61,381
Stock-based compensation	145,722	1,583
Warrants issued to non-employees		1,609
Gain on settled accounts payable	(81,200)
Gain on extinguishment of debt		(250,200)
Changes in current assets and liabilities:
Accounts receivable	2,321
Inventory	(3,530)	33,660
Prepaid and other current assets	29,412	14,019
Deferred offering costs	236,353
Accounts payable	(157,801)	(76,513)
Accrued liabilities	(477,475)	53,229
Net cash used in operating activities	(1,811,708)	(717,491)
Cash flows from investing activities:
Purchase of property and equipment	(7,247)
Net cash used in investing activities	(7,247)
Cash flows from financing activities:
Issuance of common stock in IPO, net of fees	5,194,740
Issuance of warrants in IPO	17,250
Principal repayments of finance lease obligations	(38,796)
Net cash provided by investing activities	5,173,194
Net change in cash and cash equivalents during the period	3,354,239	(717,491)
Cash and cash equivalents, beginning of period	918,260	723,481
Cash and cash equivalents, end of period	4,272,499	$ 5,990
SUPPLEMENTAL DISCLOSURES OF NON-CASH TRANSACTIONS:
Accrued interest on Bridge Notes converted to common stock	165,516
Financed insurance premiums	426,762
Warrants issued as underwriter compensation	$ 39,953